Activation	O
of	O
E2F	B-protein
-mediated	O
transcription	O
by	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
I	I-protein
Tax	I-protein
protein	I-protein
in	O
a	O
p16	B-cell_line
(	I-cell_line
INK4A	I-cell_line
)	I-cell_line
-negative	I-cell_line
T-cell	I-cell_line
line	I-cell_line
.	O

The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
causative	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O

Although	O
the	O
exact	O
mechanism	O
by	O
which	O
HTLV-I	O
contributes	O
to	O
leukemogenesis	O
is	O
still	O
unclear	O
,	O
the	O
Tax	B-protein
protein	I-protein
is	O
thought	O
to	O
play	O
a	O
major	O
role	O
in	O
this	O
process	O
.	O

This	O
40-kDa	O
polypeptide	O
is	O
able	O
to	O
interact	O
with	O
the	O
tumor	B-protein
suppressor	I-protein
p16	B-protein
(	I-protein
INK4A	I-protein
)	I-protein
.	O

Consequently	O
,	O
Tax	B-protein
can	O
activate	O
the	O
signaling	O
pathway	O
that	O
lead	O
to	O
the	O
release	O
of	O
E2F	B-protein
that	O
in	O
turn	O
induces	O
expression	O
of	O
factors	O
required	O
for	O
cell	O
cycle	O
progression	O
.	O

In	O
this	O
paper	O
,	O
we	O
demonstrate	O
that	O
Tax	B-protein
can	O
also	O
activate	O
E2F	B-protein
-mediated	O
transcription	O
independently	O
of	O
p16	B-protein
(	I-protein
INK4A	I-protein
)	I-protein
.	O

Indeed	O
,	O
when	O
Tax	B-protein
is	O
coexpressed	O
with	O
the	O
E2F-1	B-protein
transcription	B-protein
factor	I-protein
in	O
CEM	B-cell_line
T-cells	I-cell_line
,	O
which	O
lack	O
expression	O
of	O
p16	B-protein
(	I-protein
INK4A	I-protein
)	I-protein
,	O
it	O
strongly	O
potentiates	O
the	O
E2F	B-protein
-dependent	O
activation	O
of	O
a	O
reporter	O
construct	O
driven	O
by	O
a	O
promoter	O
containing	O
E2F	B-DNA
binding	I-DNA
sites	I-DNA
.	O

This	O
stimulation	O
is	O
abrogated	O
by	O
mutations	O
affecting	O
the	O
E2F-binding	B-DNA
sites	I-DNA
.	O

In	O
addition	O
,	O
Tax	B-protein
also	O
stimulates	O
the	O
transcription	O
of	O
the	O
E2F-1	B-DNA
gene	I-DNA
itself	O
.	O

Using	O
Tax	B-protein
mutants	O
that	O
fail	O
to	O
activate	O
either	O
ATF	B-protein
-or	O
NF-kappaB-dependent	B-DNA
promoters	I-DNA
and	O
different	O
5	B-DNA
'	I-DNA
truncation	I-DNA
mutants	I-DNA
of	O
the	O
E2F-1	B-DNA
promoter	I-DNA
,	O
we	O
show	O
that	O
the	O
Tax	B-protein
-dependent	O
transcriptional	O
control	O
of	O
the	O
E2F1	B-DNA
gene	I-DNA
involves	O
,	O
at	O
least	O
in	O
part	O
,	O
the	O
ATF	B-DNA
binding	I-DNA
site	I-DNA
located	O
in	O
the	O
E2F-1	B-DNA
promoter	I-DNA
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

36	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
4	NULL
,	NULL
pp	NULL
.	NULL

23598-23604	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Activation	NULL
of	NULL
E2F-mediated	NULL
Transcription	NULL
by	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
Tax	NULL
Protein	NULL
in	NULL
a	NULL
pl	NULL
T-cell	NULL
Line*	NULL
6	NULL
``	NULL
~*-negative	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
23	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
22	NULL
,	NULL
1998	NULL
)	NULL
Isabelle	NULL
Lemasson	NULL
#	NULL
§	NULL
,	NULL
Sabine	NULL
Thébault	NULL
?	NULL

#	NULL
1	NULL
,	NULL
Claude	NULL
Sardet	NULL
]	NULL
,	NULL
Christian	NULL
Devaux	NULL
}	NULL
,	NULL
and	NULL
Jean-Michel	NULL
Mesnard	NULL
}	NULL
#	NULL
**	NULL
From	NULL
the	NULL
{	NULL
Laboratoire	NULL
Infections	NULL
Rétrovirales	NULL
et	NULL
Signalisation	NULL
Cellulaire	NULL
,	NULL
CRBM/CNRS	NULL
UPR1086	NULL
,	NULL
Institut	NULL
de	NULL
Biologie	NULL
,	NULL
4	NULL
Bd	NULL
Henri	NULL
IV	NULL
,	NULL
34060	NULL
Montpellier	NULL
,	NULL
France	NULL
\|Institut	NULL
de	NULL
Génétique	NULL
Moléculaire	NULL
de	NULL
Montpellier	NULL
,	NULL
CNRS	NULL
UMR	NULL
5535	NULL
,	NULL
1919	NULL
Route	NULL
de	NULL
Mende	NULL
,	NULL
34033	NULL
Montpellier	NULL
Cedex	NULL
1	NULL
,	NULL
France	NULL
The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
a	NULL
causative	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
mechanism	NULL
by	NULL
which	NULL
HTLV-I	NULL
contributes	NULL
to	NULL
leuke-mogenesis	NULL
is	NULL
still	NULL
unclear	NULL
,	NULL
the	NULL
Tax	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
this	NULL
process	NULL
.	NULL

This	NULL
40-kDa	NULL
polypep-tide	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
tumor	NULL
suppressor	NULL
p16	NULL
``	NULL
~**	NULL
,	NULL
Consequently	NULL
,	NULL
Tax	NULL
can	NULL
activate	NULL
the	NULL
signaling	NULL
pathway	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
release	NULL
of	NULL
E2F	NULL
that	NULL
in	NULL
turn	NULL
induces	NULL
expression	NULL
of	NULL
factors	NULL
required	NULL
for	NULL
cell	NULL
cycle	NULL
pro-gression	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax	NULL
can	NULL
also	NULL
activate	NULL
E2F-mediated	NULL
transcription	NULL
independently	NULL
of	NULL
p16	NULL
``	NULL
~**	NULL
.	NULL

Indeed	NULL
,	NULL
when	NULL
Tax	NULL
is	NULL
coexpressed	NULL
with	NULL
the	NULL
E2F-1	NULL
transcription	NULL
factor	NULL
in	NULL
CEM	NULL
T-cells	NULL
,	NULL
which	NULL
lack	NULL
expression	NULL
of	NULL
it	NULL
strongly	NULL
potentiates	NULL
the	NULL
E2F-dependent	NULL
activation	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
a	NULL
promoter	NULL
containing	NULL
E2F	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
stimulation	NULL
is	NULL
abrogated	NULL
by	NULL
mutations	NULL
affecting	NULL
the	NULL
E2F-binding	NULL
sites	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
also	NULL
stimulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
EZF-1	NULL
gene	NULL
itself	NULL
.	NULL

Using	NULL
Tax	NULL
mutants	NULL
that	NULL
fail	NULL
to	NULL
activate	NULL
either	NULL
ATF-	NULL
or	NULL
NF-	NULL
«	NULL
B-dependent	NULL
promoters	NULL
and	NULL
different	NULL
5	NULL
'	NULL
truncation	NULL
mutants	NULL
of	NULL
the	NULL
E2F-1	NULL
promoter	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
Tax-dependent	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
EZ2F1l	NULL
gene	NULL
involves	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
ATF	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
E2F-1	NULL
promoter	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
is	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
genome	NULL
codes	NULL
for	NULL
regulatory	NULL
proteins	NULL
including	NULL
the	NULL
40-kDa	NULL
Tax	NULL
protein	NULL
,	NULL
which	NULL
transactivates	NULL
its	NULL
own	NULL
promoter	NULL
.	NULL

Tax	NULL
transactivation	NULL
involves	NULL
three	NULL
21-base	NULL
pair	NULL
regulatory	NULL
elements	NULL
containing	NULL
imperfect	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
localized	NULL
in	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Tax	NULL
interacts	NULL
directly	NULL
with	NULL
proteins	NULL
of	NULL
the	NULL
activating	NULL
transcription	NULL
factor/CRE-bind-ing	NULL
protein	NULL
(	NULL
ATF/CREB	NULL
)	NULL
family	NULL
(	NULL
5-7	NULL
)	NULL
and	NULL
increases	NULL
their	NULL
activ-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
institutional	NULL
grants	NULL
from	NULL
CNRS	NULL
and	NULL
INSERM	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Fellow	NULL
of	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
.	NULL

1	NULL
Fellow	NULL
of	NULL
the	NULL
CNRS	NULL
(	NULL
Bourse	NULL
Docteur	NULL
Ingénieur	NULL
)	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Laboratoire	NULL
Infections	NULL
Rétrovirales	NULL
et	NULL
Signalisation	NULL
Cellulaire	NULL
,	NULL
Institut	NULL
de	NULL
Biologie	NULL
,	NULL
4	NULL
Bd	NULL
Henri	NULL
IV	NULL
,	NULL
34060	NULL
Montpellier	NULL
,	NULL
France	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
83-4-67-60-86-60	NULL
;	NULL
Fax	NULL
:	NULL
83-4-67-60-44-20	NULL
;	NULL
E-mail	NULL
:	NULL
mesnard	NULL
@	NULL
crbm.cnrs-mop.fr	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HTLV-I	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
ATL	NULL
,	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
;	NULL
PISK	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
CRE-binding	NULL
protein	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
RT	NULL
,	NULL
reverse	NULL
transcriptase	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
DHFR	NULL
,	NULL
dihydrofolate	NULL
reductase	NULL
.	NULL

23598	NULL
ity	NULL
by	NULL
enhancing	NULL
their	NULL
dimerization	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Tax	NULL
stimulates	NULL
ATF/CREB	NULL
binding	NULL
to	NULL
CREB-binding	NULL
protein	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Tax	NULL
is	NULL
highly	NULL
pleiotropic	NULL
,	NULL
as	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transcriptionally	NULL
stimulate	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cellular	NULL
genes	NULL
through	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
other	NULL
transcription	NULL
factors	NULL
including	NULL
the	NULL
p67°	NULL
``	NULL
*	NULL
``	NULL
,	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
,	NULL
Ets1l	NULL
,	NULL
NF-Y	NULL
,	NULL
and	NULL
Spl	NULL
(	NULL
10-14	NULL
)	NULL
,	NULL
and	NULL
to	NULL
repress	NULL
gene	NULL
transcription	NULL
through	NULL
factors	NULL
of	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
family	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
Tax	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
onset	NULL
of	NULL
ATL	NULL
,	NULL
but	NULL
it	NULL
still	NULL
remains	NULL
unclear	NULL
which	NULL
of	NULL
the	NULL
diverse	NULL
stimulation	NULL
activities	NULL
of	NULL
Tax	NULL
is	NULL
essential	NULL
for	NULL
immortalization	NULL
of	NULL
HTLV	NULL
-I-infected	NULL
T-lymphocytes	NULL
.	NULL

In	NULL
studies	NULL
with	NULL
Tax	NULL
mutants	NULL
(	NULL
18	NULL
)	NULL
,	NULL
transactivation	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
not	NULL
required	NULL
for	NULL
rat	NULL
fibroblast	NULL
transformation	NULL
,	NULL
whereas	NULL
Tax	NULL
mutants	NULL
unable	NULL
to	NULL
transactivate	NULL
the	NULL
ATF/CREB	NULL
pathway	NULL
were	NULL
described	NULL
to	NULL
be	NULL
not	NULL
oncogenic	NULL
(	NULL
19	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
an	NULL
observation	NULL
of	NULL
Yamaoka	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
of	NULL
rat	NULL
fibroblasts	NULL
by	NULL
Tax	NULL
.	NULL

Nevertheless	NULL
,	NULL
transduction	NULL
in	NULL
human	NULL
primary	NULL
T-lymphocytes	NULL
of	NULL
a	NULL
Tax	NULL
mutant	NULL
that	NULL
is	NULL
active	NULL
for	NULL
ATF/CREB	NULL
but	NULL
inactive	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
resulted	NULL
in	NULL
permanent	NULL
growth	NULL
of	NULL
the	NULL
cells	NULL
suggesting	NULL
that	NULL
Tax	NULL
can	NULL
induce	NULL
immortalization	NULL
of	NULL
T-lymphocytes	NULL
through	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
(	NULL
21	NULL
)	NULL
.	NULL

E2F	NULL
cellular	NULL
activity	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
heterodimeric	NULL
association	NULL
(	NULL
22	NULL
)	NULL
of	NULL
two	NULL
families	NULL
of	NULL
proteins	NULL
,	NULL
E2F	NULL
's	NULL
(	NULL
E2F1-5	NULL
)	NULL
(	NULL
23-25	NULL
)	NULL
and	NULL
DPs	NULL
(	NULL
DP1-2	NULL
)	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

All	NULL
E2Fs	NULL
share	NULL
a	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
,	NULL
and	NULL
an	NULL
acidic	NULL
residue-rich	NULL
region	NULL
involved	NULL
in	NULL
transcription	NULL
activation	NULL
.	NULL

While	NULL
bound	NULL
on	NULL
DNA	NULL
,	NULL
they	NULL
exist	NULL
as	NULL
free	NULL
heterodimers	NULL
E2F/DP	NULL
or	NULL
associated	NULL
in	NULL
larger	NULL
complexes	NULL
containing	NULL
members	NULL
of	NULL
the	NULL
pRB	NULL
tumor	NULL
suppressor	NULL
(	NULL
pRB	NULL
,	NULL
p107	NULL
,	NULL
p130	NULL
)	NULL
and	NULL
of	NULL
the	NULL
cyclin/cyclin-dependent	NULL
kinases	NULL
(	NULL
cyeB/cdk2	NULL
,	NULL
cyeA/cdk2	NULL
)	NULL
protein	NULL
families	NULL
.	NULL

E2F/DP	NULL
transcription	NULL
factors	NULL
can	NULL
act	NULL
as	NULL
repressors	NULL
(	NULL
large	NULL
complexes	NULL
)	NULL
or	NULL
as	NULL
activators	NULL
(	NULL
free	NULL
het-erodimers	NULL
)	NULL
of	NULL
their	NULL
target	NULL
genes	NULL
.	NULL

The	NULL
pocket	NULL
proteins	NULL
pRB	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
inhibit	NULL
E2F/DP	NULL
transactivation	NULL
and	NULL
probably	NULL
that	NULL
of	NULL
other	NULL
surrounding	NULL
transcription	NULL
factors	NULL
close	NULL
to	NULL
E2F	NULL
's	NULL
on	NULL
DNA	NULL
.	NULL

E2F/DP	NULL
association	NULL
with	NULL
the	NULL
pocket	NULL
proteins	NULL
is	NULL
con-trolled	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
cyclin/edks	NULL
(	NULL
cyeD/cdk4	NULL
,	NULL
cycF/	NULL
cdk2	NULL
,	NULL
cycA/cdk2	NULL
)	NULL
-dependent	NULL
phosphorylation	NULL
of	NULL
the	NULL
pocket	NULL
proteins	NULL
and	NULL
of	NULL
E2F/DP	NULL
.	NULL

This	NULL
control	NULL
of	NULL
edks	NULL
on	NULL
E2F	NULL
activity	NULL
links	NULL
the	NULL
cell-cycle	NULL
machinery	NULL
to	NULL
gene-regulated	NULL
expression	NULL
.	NULL

All	NULL
E2F/DP	NULL
family	NULL
members	NULL
recognize	NULL
a	NULL
canonical	NULL
sequence	NULL
,	NULL
5'-T	NULL
(	NULL
NNJT	NULL
(	NULL
CIG	NULL
)	NULL
(	NULL
C/IG	NULL
)	NULL
CGC-3	NULL
'	NULL
(	NULL
29	NULL
)	NULL
that	NULL
is	NULL
critical	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
many	NULL
genes	NULL
controlling	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
such	NULL
as	NULL
:	NULL
(	NULL
i	NULL
)	NULL
DNA	NULL
and	NULL
chromatin	NULL
synthesis	NULL
proteins	NULL
:	NULL
dihydrofolate	NULL
reductase	NULL
(	NULL
DHFR	NULL
)	NULL
,	NULL
thymidine	NULL
kinase	NULL
,	NULL
DNA	NULL
polymerase	NULL
a	NULL
,	NULL
proliferating	NULL
cell	NULL
nuclear	NULL
antigen	NULL
,	NULL
histone	NULL
H2A	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
cell	NULL
cycle	NULL
regulatory	NULL
proteins	NULL
:	NULL
cyclin	NULL
A	NULL
,	NULL
cyclin	NULL
E	NULL
,	NULL
cyclin	NULL
D1	NULL
,	NULL
p107	NULL
,	NULL
pRB	NULL
,	NULL
edc6	NULL
,	NULL
hsorc1	NULL
,	NULL
E2F-1	NULL
,	NULL
and	NULL
E2F-2	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
cellular	NULL
proto-oncogenes	NULL
:	NULL
including	NULL
c	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
myc	NULL
,	NULL
N-myce	NULL
,	NULL
erb-B	NULL
and	NULL
B-myb	NULL
.	NULL

A	NULL
detailed	NULL
study	NULL
of	NULL
E2F	NULL
protein	NULL
complexes	NULL
in	NULL
T-cells	NULL
demonstrated	NULL
that	NULL
the	NULL
prevailing	NULL
E2F	NULL
complexes	NULL
contain	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
associated	NULL
with	NULL
DP-1	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
crucial	NULL
role	NULL
of	NULL
E2F	NULL
target	NULL
genes	NULL
in	NULL
cell	NULL
proliferation	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
E2F	NULL
activity	NULL
by	NULL
HTLV-I	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
proliferation	NULL
and	NULL
transformation	NULL
of	NULL
T-cells	NULL
in	NULL
ATL	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
this	NULL
model	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
HTLV	NULL
-I-infected	NULL
T-cell	NULL
lines	NULL
and	NULL
leukemic	NULL
cells	NULL
obtained	NULL
from	NULL
ATL	NULL
patients	NULL
contained	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
E2F	NULL
and	NULL
that	NULL
Tax	NULL
enhanced	NULL
this	NULL
E2F	NULL
activity	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
31	NULL
)	NULL
.	NULL

As	NULL
proposed	NULL
recently	NULL
(	NULL
32	NULL
)	NULL
,	NULL
it	NULL
is	NULL
believed	NULL
that	NULL
Tax	NULL
mediates	NULL
this	NULL
effect	NULL
via	NULL
its	NULL
direct	NULL
interaction	NULL
with	NULL
the	NULL
cdk	NULL
inhibitor	NULL
p16'~**	NULL
(	NULL
83	NULL
,	NULL
34	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
would	NULL
lead	NULL
to	NULL
the	NULL
following	NULL
successive	NULL
events	NULL
(	NULL
35	NULL
)	NULL
:	NULL
(	NULL
i	NULL
)	NULL
an	NULL
increase	NULL
in	NULL
cyclin	NULL
D/cdk4	NULL
kinase	NULL
activity	NULL
in	NULL
infected	NULL
cells	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
an	NULL
enhanced	NULL
level	NULL
of	NULL
phosphorylation	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
family	NULL
(	NULL
pRB	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
)	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
an	NULL
increase	NULL
in	NULL
EZ2F	NULL
transcriptional	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax	NULL
also	NULL
stimulates	NULL
the	NULL
E2F	NULL
activity	NULL
via	NULL
other	NULL
mechanisms	NULL
.	NULL

Indeed	NULL
,	NULL
using	NULL
transient	NULL
transfection	NULL
analysis	NULL
,	NULL
we	NULL
demonstrate	NULL
here	NULL
that	NULL
Tax	NULL
remains	NULL
able	NULL
to	NULL
stimulate	NULL
gene	NULL
expression	NULL
through	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
in	NULL
the	NULL
p16	NULL
``	NULL
~	NULL
``	NULL
*-negative	NULL
CEM	NULL
T-cell	NULL
line	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
stimulation	NULL
by	NULL
Tax	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
E2F	NULL
motifs	NULL
is	NULL
abrogated	NULL
by	NULL
mutations	NULL
that	NULL
affect	NULL
the	NULL
E2F	NULL
binding	NULL
sites	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax	NULL
regulates	NULL
E2F-1	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
and	NULL
that	NULL
this	NULL
transcriptional	NULL
control	NULL
depends	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
on	NULL
the	NULL
ATF	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
E2F-1	NULL
gene	NULL
promoter	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
Tax	NULL
can	NULL
likely	NULL
disregulate	NULL
the	NULL
machinery	NULL
controlling	NULL
cell	NULL
cycle	NULL
progression	NULL
not	NULL
only	NULL
by	NULL
activating	NULL
E2F-dependent	NULL
transcription	NULL
but	NULL
also	NULL
by	NULL
stimulating	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
E2F-1	NULL
gene	NULL
itself	NULL
.	NULL

Since	NULL
overexpression	NULL
of	NULL
E2F-1	NULL
in	NULL
mammalian	NULL
cells	NULL
can	NULL
cause	NULL
oncogenesis	NULL
(	NULL
86-38	NULL
)	NULL
,	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
E2F-1	NULL
promoter	NULL
by	NULL
Tax	NULL
could	NULL
be	NULL
an	NULL
important	NULL
step	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
HTLV-I	NULL
transformation	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells-The	NULL
lymphoblastoid	NULL
CEM	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
HTLV-I-in-fected	NULL
MT4	NULL
and	NULL
C8166	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
89	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
origins	NULL
of	NULL
the	NULL
HSB-2	NULL
cell	NULL
line	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

JPX-9	NULL
is	NULL
a	NULL
clone	NULL
of	NULL
Jurkat	NULL
cells	NULL
stably	NULL
transfected	NULL
by	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
in	NULL
which	NULL
Tax	NULL
expression	NULL
is	NULL
dependent	NULL
on	NULL
heavy	NULL
metal	NULL
ions	NULL
(	NULL
42	NULL
)	NULL
.	NULL

JPX/M	NULL
cells	NULL
correspond	NULL
to	NULL
cells	NULL
transfected	NULL
by	NULL
a	NULL
mutant	NULL
plasmid	NULL
in	NULL
which	NULL
a	NULL
frameshift	NULL
mutation	NULL
is	NULL
introduced	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
Tax	NULL
gene	NULL
(	NULL
42	NULL
)	NULL
;	NULL
in	NULL
CdCl	NULL
,	NULL
-	NULL
or	NULL
ZnCl	NULL
,	NULL
-treated	NULL
JPX/M	NULL
cells	NULL
,	NULL
the	NULL
mutant	NULL
Tax	NULL
gene	NULL
is	NULL
induced	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
but	NULL
no	NULL
functional	NULL
Tax	NULL
protein	NULL
is	NULL
produced	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
penicillin/streptomycin	NULL
antibiotic	NULL
mixture	NULL
,	NULL
1	NULL
%	NULL
Glu-tamax	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Eragny	NULL
,	NULL
France	NULL
)	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
to	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
.	NULL

Plasmids-The	NULL
Tax	NULL
expression	NULL
vector	NULL
pSG-Tax	NULL
and	NULL
the	NULL
Tax	NULL
mutants	NULL
M9	NULL
,	NULL
M21	NULL
,	NULL
M22	NULL
,	NULL
and	NULL
M47	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
description	NULL
of	NULL
the	NULL
luciferase	NULL
expression	NULL
plasmids	NULL
p3xE2F-WT-luc	NULL
,	NULL
p3xE2F-MUT-lue	NULL
,	NULL
pDHFR-luc	NULL
,	NULL
and	NULL
pCycE-lue	NULL
containing	NULL
,	NULL
respectively	NULL
,	NULL
three	NULL
E2F	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
sites	NULL
,	NULL
and	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
cyclin	NULL
E	NULL
or	NULL
DHFR	NULL
gene	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
have	NULL
been	NULL
published	NULL
elsewhere	NULL
(	NULL
29	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vectors	NULL
pCMV-E2F-1	NULL
,	NULL
pCSMYC-E2F-4	NULL
,	NULL
and	NULL
pDP1	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
the	NULL
deleted	NULL
E2F-1	NULL
promoters	NULL
has	NULL
been	NULL
carried	NULL
out	NULL
by	NULL
Neuman	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
.	NULL

RT-PCR	NULL
Assays-Detection	NULL
of	NULL
retrotranscribed	NULL
RNAs	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
a	NULL
previously	NULL
published	NULL
procedure	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
E2F-1	NULL
I	NULL
(	NULL
5'-CAGATCTCCCTTAAGAGC-3	NULL
'	NULL
,	NULL
nucleotides	NULL
1041-1058	NULL
)	NULL
,	NULL
E2F-1	NULL
II	NULL
(	NULL
5'-CAGTCGAAGAGGTCTCTG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
1582-1599	NULL
,	NULL
antisense	NULL
mRNA	NULL
)	NULL
,	NULL
GAPDH	NULL
I	NULL
(	NULL
5-TGAGAAGTATGACAACAGC-3	NULL
'	NULL
,	NULL
nucleotides	NULL
8806-3824	NULL
)	NULL
,	NULL
and	NULL
GAPDH	NULL
II	NULL
(	NULL
5'-TCCACCACTGACACGTTG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
4894-4411	NULL
,	NULL
antisense	NULL
mRNA	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
primer	NULL
pair	NULL
Tax2/TRU2	NULL
(	NULL
17	NULL
)	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
retrotranscribed	NULL
Tax	NULL
mRNA	NULL
.	NULL

23599	NULL
Transfections	NULL
and	NULL
Luciferase	NULL
Assays-CEM	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
according	NULL
to	NULL
the	NULL
previously	NULL
published	NULL
procedure	NULL
(	NULL
49	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
a	NULL
B-galactosidase-containing	NULL
plasmid	NULL
(	NULL
pACB1	NULL
)	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
for	NULL
controlling	NULL
of	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
series	NULL
of	NULL
transfection	NULL
was	NULL
equal	NULL
,	NULL
the	NULL
balance	NULL
being	NULL
made	NULL
up	NULL
with	NULL
empty	NULL
pSG-5	NULL
vector	NULL
without	NULL
Tax	NULL
.	NULL

Cell	NULL
extracts	NULL
equalized	NULL
for	NULL
protein	NULL
content	NULL
were	NULL
used	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
.	NULL

Western	NULL
Blot	NULL
Assay-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
were	NULL
electrophoresed	NULL
onto	NULL
10	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
and	NULL
blotted	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
a	NULL
blocking	NULL
solution	NULL
(	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
milk	NULL
and	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
antiserum	NULL
.	NULL

After	NULL
1	NULL
h	NULL
at	NULL
20	NULL
°C	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
+	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
goat	NULL
anti-mouse	NULL
immunoglobulin-peroxydase	NULL
conjugate	NULL
(	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reagent	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
exposed	NULL
for	NULL
0.5	NULL
to	NULL
5	NULL
min	NULL
to	NULL
Hyperfilms-ECL	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Anti-E2F-1	NULL
mAb	NULL
and	NULL
anti-actin	NULL
mAb	NULL
C4	NULL
were	NULL
purchased	NULL
,	NULL
respectively	NULL
,	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
ICN	NULL
Biomedicals	NULL
Inc.	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
anti-Tax	NULL
was	NULL
obtained	NULL
through	NULL
the	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
,	NULL
Division	NULL
of	NULL
AIDS	NULL
,	NULL
NIAID	NULL
,	NULL
NIH	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
hybridoma	NULL
168A51-42	NULL
(	NULL
Tab176	NULL
)	NULL
was	NULL
from	NULL
Dr.	NULL
B.	NULL
Langton	NULL
(	NULL
50	NULL
)	NULL
.	NULL

RESULTS	NULL
Tax	NULL
Stimulates	NULL
E2FI-dependent	NULL
Transcription	NULL
in	NULL
the	NULL
p16	NULL
``	NULL
negative	NULL
CEM	NULL
T-cell	NULL
Line-To	NULL
test	NULL
whether	NULL
Tax	NULL
might	NULL
activate	NULL
E2F-mediated	NULL
transcription	NULL
independently	NULL
of	NULL
p16	NULL
``	NULL
~	NULL
``	NULL
**	NULL
``	NULL
pathway	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
cotransfection	NULL
assays	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
defective	NULL
in	NULL
expression	NULL
of	NULL
p16	NULL
``	NULL
~***	NULL
.	NULL

It	NULL
has	NULL
been	NULL
described	NULL
that	NULL
some	NULL
tumor	NULL
cell	NULL
lines	NULL
are	NULL
unable	NULL
to	NULL
express	NULL
the	NULL
p16	NULL
``	NULL
~**	NULL
``	NULL
and	NULL
among	NULL
them	NULL
various	NULL
transformed	NULL
T-cell	NULL
lines	NULL
having	NULL
homozygous	NULL
deletions	NULL
of	NULL
the	NULL
p16	NULL
'	NULL
``	NULL
~**	NULL
``	NULL
gene	NULL
(	NULL
88	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
observations	NULL
,	NULL
no	NULL
p16'*~**	NULL
``	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
CEM	NULL
cell	NULL
line	NULL
used	NULL
in	NULL
our	NULL
study	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
first	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
DHFR	NULL
and	NULL
cyclin	NULL
E	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
be	NULL
controlled	NULL
by	NULL
the	NULL
E2F	NULL
factors	NULL
(	NULL
29	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Transient	NULL
cotransfection	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
luciferase	NULL
expression	NULL
plasmids	NULL
.	NULL

The	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
CEM	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
pSG-Tax	NULL
.	NULL

Tax	NULL
synthesis	NULL
stimulated	NULL
expression	NULL
of	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
cyclin	NULL
E	NULL
(	NULL
pCyeE-lue	NULL
)	NULL
and	NULL
DHFR	NULL
(	NULL
pDHFR-lue	NULL
)	NULL
promoters	NULL
with	NULL
a	NULL
4-	NULL
and	NULL
3.5-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

When	NULL
the	NULL
transfection	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
transcriptionally	NULL
defective	NULL
Tax	NULL
mutants	NULL
,	NULL
Tax	NULL
M9	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
Tax	NULL
M21	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
such	NULL
stimulations	NULL
were	NULL
not	NULL
detected	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
promoters	NULL
of	NULL
DHFR	NULL
and	NULL
cyclin	NULL
E	NULL
genes	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
.	NULL

To	NULL
study	NULL
possible	NULL
involvement	NULL
of	NULL
E2F	NULL
in	NULL
Tax	NULL
transactivation	NULL
of	NULL
these	NULL
cellular	NULL
promoters	NULL
,	NULL
we	NULL
first	NULL
tested	NULL
whether	NULL
Tax	NULL
might	NULL
cooperate	NULL
with	NULL
E2F	NULL
in	NULL
transactivation	NULL
.	NULL

E2F1l	NULL
and	NULL
Tax	NULL
were	NULL
coexpressed	NULL
in	NULL
presence	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
promoter	NULL
with	NULL
upstream	NULL
-binding	NULL
sites	NULL
(	NULL
p3xE2F-WT-luc	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
contains	NULL
three	NULL
E2F	NULL
binding	NULL
sites	NULL
cloned	NULL
immediately	NULL
upstream	NULL
of	NULL
a	NULL
TATA	NULL
box	NULL
controlling	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
this	NULL
reporter	NULL
was	NULL
stimulated	NULL
8.5-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
pCMV-E2F-1	NULL
alone	NULL
and	NULL
9-fold	NULL
with	NULL
pSG-Tax	NULL
alone	NULL
.	NULL

No	NULL
stimulation	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
mutants	NULL
Tax	NULL
M9	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
Tax	NULL
M21	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
Tax	NULL
stimulation	NULL
was	NULL
likely	NULL
mediated	NULL
by	NULL
endogenous	NULL
E2F	NULL
factor	NULL
.	NULL

Cotransfection	NULL
of	NULL
pSG-Tax	NULL
and	NULL
pCMV-E2F-1	NULL
induced	NULL
a	NULL
44-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
E2F-1	NULL
activity	NULL
in	NULL
the	NULL
CEM	NULL
cell	NULL
line	NULL
.	NULL

Cotransfections	NULL
with	NULL
the	NULL
transcriptionally	NULL
defective	NULL
Tax	NULL
mutants	NULL
produced	NULL
no	NULL
stimulation	NULL
of	NULL
E2F-1	NULL
activity	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
transactivation	NULL
by	NULL
Tax	NULL
may	NULL
be	NULL
ascribed	NULL
to	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
28600	NULL
Relative	NULL
luciferase	NULL
activity	NULL
im	NULL
x	NULL
e	NULL
x	NULL
o	NULL
20	NULL
fo	NULL
Z2	NULL
§	NULL
AE	NULL
7	NULL
Ce	NULL
3	NULL
a	NULL
+	NULL
l	NULL
no	NULL
}	NULL
&	NULL
C.	NULL
Bf	NULL
E	NULL
Ce	NULL
&	NULL
g	NULL
2	NULL
.	NULL

V	NULL
A	NULL
a	NULL
>	NULL
m.	NULL
fas	NULL
G	NULL
2	NULL
,	NULL
a	NULL
ed	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Tax	NULL
stimulation	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
DHFR	NULL
or	NULL
cyclin	NULL
E	NULL
promoters	NULL
.	NULL

CEM	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
cyclin	NULL
E	NULL
promoter	NULL
(	NULL
pCyeE-luc	NULL
)	NULL
or	NULL
by	NULL
DHFR	NULL
promoter	NULL
(	NULL
pDHFR-luc	NULL
)	NULL
+	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
Tax	NULL
expression	NULL
vectors	NULL
(	NULL
producing	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
Tax	NULL
or	NULL
the	NULL
transcriptionally	NULL
defective	NULL
mutant	NULL
Tax	NULL
M9	NULL
)	NULL
or	NULL
empty	NULL
pSG-5	NULL
vector	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
a	NULL
-galactosidase	NULL
containing	NULL
plasmid	NULL
(	NULL
pACB1	NULL
)	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
for	NULL
controlling	NULL
of	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cell	NULL
extracts	NULL
prepared	NULL
and	NULL
equalized	NULL
for	NULL
protein	NULL
content	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
were	NULL
used	NULL
for	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
assays	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
assayed	NULL
using	NULL
the	NULL
Promega	NULL
's	NULL
luciferase	NULL
assay	NULL
system	NULL
and	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
cyclin	NULL
E	NULL
and	NULL
DHFR	NULL
promoters	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
were	NULL
arbitrarily	NULL
given	NULL
a	NULL
value	NULL
of	NULL
1	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
these	NULL
activities	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
*	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

80	NULL
g	NULL
O	NULL
L	NULL
Relative	NULL
luciferase	NULL
activity	NULL
5	NULL
€	NULL
1	NULL
L	NULL
E2F-Box	NULL
ﬂ	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
E2F-Box	NULL
+	NULL
Tax	NULL
E2F-Box	NULL
+	NULL
Tax	NULL
M9—	NULL
]	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
M9	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Tax	NULL
stimulation	NULL
of	NULL
gene	NULL
expression	NULL
mediated	NULL
by	NULL
E2F-1	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
in	NULL
CEM	NULL
cells	NULL
using	NULL
for	NULL
each	NULL
transient	NULL
cotransfection	NULL
10	NULL
ug	NULL
of	NULL
pBxE2F-WT-luc	NULL
bearing	NULL
three	NULL
copies	NULL
of	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
mentioned	NULL
E2F-Box	NULL
in	NULL
the	NULL
figure	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pACB1	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
Tax	NULL
and	NULL
E2F-1	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
either	NULL
0.1	NULL
ug	NULL
of	NULL
pCMV-E2F-1	NULL
+	NULL
0.5	NULL
ug	NULL
of	NULL
pDP1	NULL
(	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
)	NULL
,	NULL
or	NULL
5	NULL
ug	NULL
Tax	NULL
expression	NULL
vectors	NULL
(	NULL
E2F-Box	NULL
+	NULL
Tax	NULL
or	NULL
E2F-Box	NULL
+	NULL
Tax	NULL
M9	NULL
)	NULL
,	NULL
or	NULL
0.1	NULL
ug	NULL
of	NULL
pCMV-E2F-1	NULL
+	NULL
0.5	NULL
ug	NULL
of	NULL
pDP1	NULL
+	NULL
5	NULL
ug	NULL
of	NULL
Tax	NULL
expression	NULL
vectors	NULL
(	NULL
EZF-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
or	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
M9	NULL
)	NULL
,	NULL
the	NULL
balance	NULL
of	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
being	NULL
made	NULL
up	NULL
with	NULL
pSG-5	NULL
.	NULL

Luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
E2F-Box	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
E2F-1	NULL
or/and	NULL
Tax	NULL
was	NULL
arbitrarily	NULL
given	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

(	NULL
r	NULL
=	NULL
8	NULL
)	NULL
.	NULL

a	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
E2F-1	NULL
to	NULL
the	NULL
tested	NULL
minimal	NULL
promoter	NULL
,	NULL
Tax	NULL
stimulation	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
three	NULL
mutated	NULL
E2F	NULL
binding	NULL
sites	NULL
were	NULL
analyzed	NULL
with	NULL
the	NULL
plas-	NULL
Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
80	NULL
a	NULL
o	NULL
1	NULL
Relative	NULL
luciferase	NULL
activity	NULL
ho	NULL
p	NULL
©	NULL
&	NULL
1	NULL
1	NULL
x	NULL
-	NULL
Xx	NULL
5	NULL
£	NULL
40	NULL
%	NULL
=	NULL
o-	NULL
D	NULL
Xo	NULL
H	NULL
al	NULL
=	NULL
5	NULL
$	NULL
A	NULL
5	NULL
A	NULL
MUT-Box	NULL
+	NULL
E2P-1	NULL
in	NULL
Hx	NULL
Ol	NULL
fo	NULL
+	NULL
x	NULL
el	NULL
®	NULL
Bx	NULL
O	NULL
ssl	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
MUT-Box	NULL
+	NULL
E2P-1	NULL
+	NULL
Tax-1	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Comparative	NULL
sensitivity	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
E2F	NULL
binding	NULL
sites	NULL
to	NULL
activation	NULL
by	NULL
E2F-1	NULL
or	NULL
by	NULL
E2F-1	NULL
+	NULL
Tax	NULL
.	NULL

Transient	NULL
cotransfection	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
and	NULL
luciferase	NULL
values	NULL
normalized	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pSxE2F-WT-lue	NULL
or	NULL
p3xE2F-MUT-luc	NULL
bearing	NULL
,	NULL
respectively	NULL
,	NULL
wild-type	NULL
(	NULL
E2F-Box	NULL
)	NULL
or	NULL
mutated	NULL
copies	NULL
(	NULL
MUT-Box	NULL
)	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
*	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
.	NULL

mid	NULL
p3xE2F-MUT-lue	NULL
.	NULL

The	NULL
design	NULL
of	NULL
this	NULL
mutant	NULL
,	NULL
which	NULL
converts	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
5'-TTTCGCGC-3	NULL
'	NULL
to	NULL
5'-TTgCtCGa-3	NULL
'	NULL
,	NULL
was	NULL
based	NULL
on	NULL
mutations	NULL
that	NULL
are	NULL
known	NULL
to	NULL
abolish	NULL
binding	NULL
and	NULL
activity	NULL
of	NULL
E2F	NULL
(	NULL
44	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
mutant	NULL
promoter	NULL
was	NULL
very	NULL
poorly	NULL
induced	NULL
by	NULL
Tax	NULL
and	NULL
E2F-1	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
Tax-mediated	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
was	NULL
reduced	NULL
by	NULL
5.5-fold	NULL
with	NULL
Tax	NULL
alone	NULL
and	NULL
39-fold	NULL
with	NULL
Tax	NULL
and	NULL
E2F-1	NULL
compared	NULL
with	NULL
control	NULL
promoter	NULL
.	NULL

The	NULL
mutant	NULL
promoter	NULL
still	NULL
showed	NULL
a	NULL
slight	NULL
1.5-fold	NULL
enhancement	NULL
by	NULL
Tax	NULL
,	NULL
which	NULL
corroborates	NULL
previous	NULL
published	NULL
results	NULL
(	NULL
see	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
Refs	NULL
.	NULL

51-53	NULL
)	NULL
,	NULL
and	NULL
represents	NULL
low	NULL
level	NULL
of	NULL
Tax	NULL
induction	NULL
on	NULL
a	NULL
minimal	NULL
TATA	NULL
box	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
demonstrate	NULL
that	NULL
Tax	NULL
activates	NULL
E2F-1-dependent	NULL
transcription	NULL
.	NULL

Tax	NULL
Also	NULL
Stimulates	NULL
Transcription	NULL
through	NULL
E2F4-The	NULL
E2F	NULL
family	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
subclasses	NULL
of	NULL
evolutionarily	NULL
distinct	NULL
factors	NULL
:	NULL
E2Fs-1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
pRB	NULL
;	NULL
and	NULL
E2F-4	NULL
and	NULL
E2F-5	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
p107	NULL
and	NULL
p130	NULL
,	NULL
two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
pRB	NULL
family	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
revealed	NULL
that	NULL
E2F-4	NULL
and	NULL
E2F-5	NULL
were	NULL
more	NULL
closely	NULL
related	NULL
to	NULL
each	NULL
other	NULL
than	NULL
to	NULL
E2Fs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
.	NULL

We	NULL
questioned	NULL
whether	NULL
transactivation	NULL
by	NULL
Tax	NULL
of	NULL
a	NULL
promoter	NULL
containing	NULL
E2F	NULL
binding	NULL
sites	NULL
could	NULL
be	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E2F-4	NULL
.	NULL

For	NULL
this	NULL
experiment	NULL
,	NULL
we	NULL
used	NULL
the	NULL
same	NULL
approach	NULL
as	NULL
described	NULL
for	NULL
E2F-1	NULL
,	NULL
by	NULL
testing	NULL
the	NULL
Tax	NULL
transactivation	NULL
on	NULL
wild	NULL
type	NULL
and	NULL
mutated	NULL
E2F	NULL
sites	NULL
in	NULL
cotransfection	NULL
experiments	NULL
with	NULL
or	NULL
without	NULL
E2F-4	NULL
.	NULL

Although	NULL
expression	NULL
of	NULL
E2F-4	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
pCSMYC-E2F-4	NULL
induced	NULL
a	NULL
6-fold	NULL
stimulation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
,	NULL
its	NULL
coexpression	NULL
with	NULL
pSG-Tax	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
21-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
as	NULL
showed	NULL
for	NULL
E2F-1	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
E2F	NULL
site	NULL
reduced	NULL
the	NULL
Tax	NULL
activity	NULL
on	NULL
E2F-4	NULL
,	NULL
confirming	NULL
that	NULL
stimulation	NULL
by	NULL
Tax	NULL
was	NULL
due	NULL
to	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
E2F-4	NULL
to	NULL
the	NULL
E2F	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
not	NULL
only	NULL
does	NULL
Tax	NULL
activate	NULL
E2F-1-dependent	NULL
transcrip-tion	NULL
,	NULL
it	NULL
is	NULL
also	NULL
able	NULL
to	NULL
stimulate	NULL
the	NULL
E2F-4	NULL
transcriptional	NULL
activity	NULL
.	NULL

Tax	NULL
Stimulates	NULL
E2F-1	NULL
Gene	NULL
Expression-As	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
the	NULL
E2F1	NULL
gene	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
its	NULL
own	NULL
prod-uct	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
Tax	NULL
would	NULL
also	NULL
stimulate	NULL
the	NULL
E2F1l	NULL
promoter	NULL
,	NULL
thereby	NULL
enhancing	NULL
its	NULL
effect	NULL
on	NULL
cellular	NULL
E2F	NULL
activity	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
>	NULL
-	NULL
|	NULL
tte	NULL
g	NULL
``	NULL
Tax	NULL
»	NULL
Like	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
E2F-1	NULL
protein	NULL
expression	NULL
in	NULL
human	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
HTLV-I	NULL
.	NULL

A	NULL
,	NULL
for	NULL
an	NULL
immunoblot	NULL
analysis	NULL
,	NULL
20	NULL
ug	NULL
protein	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
and	NULL
HSB-2	NULL
cells	NULL
and	NULL
from	NULL
Tax-positive	NULL
T-cells	NULL
,	NULL
MT4	NULL
and	NULL
C8166	NULL
,	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblot-ting	NULL
using	NULL
anti-E2F-1	NULL
mAb	NULL
(	NULL
top	NULL
)	NULL
or	NULL
anti-Tax	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

B	NULL
,	NULL
naphthol	NULL
blue	NULL
black-stained	NULL
Western	NULL
blot	NULL
containing	NULL
20	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
,	NULL
HSB-2	NULL
,	NULL
MT4	NULL
,	NULL
and	NULL
C8166	NULL
cells	NULL
showing	NULL
that	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
proteins	NULL
was	NULL
loaded	NULL
into	NULL
each	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
first	NULL
checked	NULL
the	NULL
level	NULL
of	NULL
endogenous	NULL
E2F-1	NULL
protein	NULL
in	NULL
two	NULL
human	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
HTLV-I	NULL
,	NULL
MT4	NULL
,	NULL
and	NULL
C8166	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
immuno-blotting	NULL
analysis	NULL
using	NULL
an	NULL
anti-E2F-1	NULL
mAb	NULL
indicated	NULL
that	NULL
expression	NULL
of	NULL
E2F-1	NULL
was	NULL
increased	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
Tax-positive	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
level	NULL
seen	NULL
in	NULL
uninfected	NULL
Jurkat	NULL
and	NULL
HSB-2	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
Tax	NULL
expression	NULL
could	NULL
stimulate	NULL
E2F-1	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
whether	NULL
this	NULL
effect	NULL
was	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
transcriptional	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
E2F-1	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
then	NULL
compared	NULL
E2F-1	NULL
mRNA	NULL
levels	NULL
in	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Tax	NULL
protein	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
JPX-9	NULL
clone	NULL
of	NULL
Jurkat	NULL
cells	NULL
containing	NULL
the	NULL
Tax	NULL
gene	NULL
under	NULL
a	NULL
promoter	NULL
whose	NULL
expression	NULL
is	NULL
stimulated	NULL
by	NULL
heavy	NULL
metal	NULL
ions	NULL
(	NULL
42	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
the	NULL
level	NULL
of	NULL
E2F-1	NULL
mRNA	NULL
was	NULL
clearly	NULL
increased	NULL
in	NULL
JPX-9	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
ZnCl	NULL
,	NULL
or	NULL
CdCl	NULL
,	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
of	NULL
control	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
unchanged	NULL
.	NULL

JPX/M	NULL
cells	NULL
that	NULL
expressed	NULL
nonfunctional	NULL
Tax	NULL
were	NULL
treated	NULL
in	NULL
the	NULL
same	NULL
way	NULL
but	NULL
did	NULL
not	NULL
show	NULL
any	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
E2F-1	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
stimulation	NULL
of	NULL
E2F-1	NULL
mRNA	NULL
synthesis	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

We	NULL
finally	NULL
tested	NULL
whether	NULL
Tax	NULL
can	NULL
stimulate	NULL
E2F-1	NULL
promoter	NULL
activity	NULL
.	NULL

Transfection	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
plasmid	NULL
pGL2-AN	NULL
that	NULL
contains	NULL
the	NULL
E2F-1	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

Cotransfection	NULL
of	NULL
pSG-Tax	NULL
and	NULL
pGL2-AN	NULL
induced	NULL
a	NULL
5.5-fold	NULL
stimulation	NULL
in	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Tax	NULL
is	NULL
effectively	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
E2F-1	NULL
promoter	NULL
.	NULL

Tax	NULL
Transactivation	NULL
of	NULL
the	NULL
E2F-1	NULL
Promoter	NULL
Is	NULL
Dependent	NULL
,	NULL
at	NULL
Least	NULL
in	NULL
Part	NULL
,	NULL
on	NULL
the	NULL
ATF	NULL
Binding	NULL
Site-To	NULL
further	NULL
explore	NULL
the	NULL
mechanisms	NULL
underlying	NULL
this	NULL
transcriptional	NULL
activation	NULL
the	NULL
same	NULL
cotransfection	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
presence	NULL
of	NULL
Tax	NULL
mutants	NULL
that	NULL
fail	NULL
to	NULL
activate	NULL
ATF	NULL
(	NULL
M47	NULL
)	NULL
-	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
M22	NULL
)	NULL
-de-pendent	NULL
promoters	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Tax	NULL
M22	NULL
activated	NULL
the	NULL
promoter	NULL
to	NULL
28601	NULL
A	NULL
zncl	NULL
,	NULL
e	NULL
e	NULL
e	NULL
CdCl	NULL
,	NULL
-	NULL
w	NULL
&	NULL
+	NULL
Hit	NULL
*	NULL
``	NULL
¥e	NULL
E2F-	NULL
1	NULL
mRNA	NULL
»	NULL
GAPDHmRNA	NULL
-|	NULL
ie	NULL
commme	NULL
'	NULL
l	NULL
‘	NULL
a	NULL
X	NULL
*~	NULL
m	NULL
actin	NULL
&	NULL
B	NULL
e	NULL
CdCly	NULL
=-	NULL
=	NULL
=	NULL
+	NULL
E2F-	NULL
1	NULL
mRNA	NULL
»	NULL
GAPDHmRNA	NULL
&	NULL
Tax	NULL
mRNA	NULL
»	NULL
ran	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
EZF-1	NULL
mRNA	NULL
in	NULL
JPX-9	NULL
(	NULL
4	NULL
)	NULL
and	NULL
JPX/M	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
treated	NULL
with	NULL
CdCl	NULL
,	NULL
or	NULL
ZnCl	NULL
,	NULL
.	NULL

A	NULL
,	NULL
PCR	NULL
analysis	NULL
(	NULL
top	NULL
)	NULL
of	NULL
retrotranscribed	NULL
mRNA	NULL
in	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
medium	NULL
containing	NULL
120	NULL
uM	NULL
ZnCl	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
5	NULL
uM	NULL
CdCl	NULL
,	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
E2F-1	NULL
I/E2F-1	NULL
II	NULL
oligonucleotide	NULL
primer	NULL
pair	NULL
.	NULL

A	NULL
control	NULL
is	NULL
shown	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
in	NULL
which	NULL
a	NULL
cDNA-free	NULL
sample	NULL
was	NULL
prepared	NULL
for	NULL
PCR	NULL
and	NULL
treated	NULL
like	NULL
the	NULL
extracted	NULL
samples	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
were	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
hybridized	NULL
with	NULL
a	NULL
radiolabeled	NULL
E2F-1	NULL
probe	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
GAPDH	NULL
mRNA	NULL
is	NULL
shown	NULL
as	NULL
control	NULL
.	NULL

Tax	NULL
expression	NULL
was	NULL
checked	NULL
by	NULL
Western	NULL
blotting	NULL
by	NULL
using	NULL
anti-Tax	NULL
mAb	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

B	NULL
,	NULL
PCR	NULL
analyses	NULL
of	NULL
retrotranscribed	NULL
E2F-1	NULL
,	NULL
GAPDH	NULL
,	NULL
and	NULL
Tax	NULL
mRNA	NULL
in	NULL
JPX/M	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
medium	NULL
containing	NULL
120	NULL
um	NULL
ZnCl	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
5	NULL
uM	NULL
CdCl	NULL
,	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
corresponds	NULL
to	NULL
cDNA-free	NULL
samples	NULL
.	NULL

levels	NULL
similar	NULL
to	NULL
wild	NULL
type	NULL
Tax	NULL
whereas	NULL
Tax	NULL
M47	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
only	NULL
about	NULL
2-fold	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

From	NULL
these	NULL
results	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
Tax	NULL
transactivation	NULL
of	NULL
the	NULL
E2F-1	NULL
promoter	NULL
is	NULL
independent	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
involves	NULL
the	NULL
ATF	NULL
pathway	NULL
.	NULL

To	NULL
further	NULL
map	NULL
the	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
E2F1	NULL
promoter	NULL
required	NULL
for	NULL
activation	NULL
by	NULL
Tax	NULL
,	NULL
a	NULL
series	NULL
of	NULL
5	NULL
truncation	NULL
mutants	NULL
of	NULL
pGL2-AN	NULL
(	NULL
48	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
pSG-Tax	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
deletion	NULL
that	NULL
encompasses	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
from	NULL
position	NULL
-211	NULL
to	NULL
-131	NULL
,	NULL
increased	NULL
the	NULL
stimulation	NULL
by	NULL
Tax	NULL
(	NULL
from	NULL
6-fold	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
to	NULL
10-fold	NULL
for	NULL
the	NULL
deleted	NULL
promoter	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
Spl	NULL
binding	NULL
sites	NULL
could	NULL
have	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
E2F-1	NULL
promoter	NULL
activation	NULL
by	NULL
Tax	NULL
.	NULL

Although	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
CCAAT	NULL
box	NULL
had	NULL
no	NULL
effect	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
ATF	NULL
binding	NULL
motif	NULL
significantly	NULL
reduced	NULL
the	NULL
activation	NULL
by	NULL
Tax	NULL
(	NULL
from	NULL
10-fold	NULL
to	NULL
5.5-fold	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
deleted	NULL
pGL2-AN	NULL
vector	NULL
containing	NULL
the	NULL
E2F	NULL
binding	NULL
sites	NULL
was	NULL
still	NULL
stimulated	NULL
by	NULL
Tax	NULL
,	NULL
confirming	NULL
the	NULL
results	NULL
already	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
with	NULL
the	NULL
plasmid	NULL
p3xE2F-WT-lue	NULL
that	NULL
contained	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
confirm	NULL
the	NULL
involvement	NULL
of	NULL
an	NULL
ATF-dependent	NULL
pathway	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
E2F-1	NULL
gene	NULL
by	NULL
Tax	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
283602	NULL
ATF	NULL
Pathway	NULL
Is	NULL
Necessary	NULL
but	NULL
Not	NULL
Sufficient	NULL
to	NULL
Explain	NULL
the	NULL
Transactivation	NULL
by	NULL
Tax-In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
show	NULL
that	NULL
Tax	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
E2F-1-dependent	NULL
transcription	NULL
in	NULL
CEM	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
to	NULL
stimulate	NULL
E2F-1	NULL
gene	NULL
transcription	NULL
through	NULL
the	NULL
ATF-responsive	NULL
element	NULL
localized	NULL
in	NULL
the	NULL
promoter	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
E2F-1	NULL
gene	NULL
by	NULL
Tax	NULL
could	NULL
explain	NULL
how	NULL
Tax	NULL
transactivates	NULL
E2F-1-dependent	NULL
transcription	NULL
.	NULL

To	NULL
determine	NULL
effects	NULL
of	NULL
this	NULL
stimulation	NULL
in	NULL
our	NULL
tests	NULL
,	NULL
transfection	NULL
assays	NULL
already	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
performed	NULL
again	NULL
,	NULL
but	NULL
in	NULL
these	NULL
assays	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
plasmid	NULL
p3xE2F-WT-lue	NULL
containing	NULL
E2F-binding	NULL
sites	NULL
,	NULL
the	NULL
E2F-1	NULL
expression	NULL
vector	NULL
pCMV-E2F-1	NULL
,	NULL
together	NULL
with	NULL
the	NULL
mutant	NULL
Tax	NULL
M47	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
the	NULL
wild	NULL
type	NULL
Tax	NULL
and	NULL
the	NULL
mutant	NULL
Tax	NULL
M22	NULL
induced	NULL
about	NULL
a	NULL
40-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
whereas	NULL
Tax	NULL
M47	NULL
stimulated	NULL
A	NULL
®	NULL
B	NULL
>	NULL
§	NULL
8	NULL
ﬁg	NULL
<	NULL
0	NULL
€	NULL
&	NULL
3	NULL
*	NULL
4	NULL
&	NULL
00	NULL
f	NULL
Io	NULL
&	NULL
f	NULL
f	NULL
RI	NULL
¥	NULL
z	NULL
&	NULL
4	NULL
100000	NULL
+0000	NULL
+	NULL
ee	NULL
2	NULL
-	NULL
g	NULL
2	NULL
-	NULL
2	NULL
B	NULL
Twp	NULL
“	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Tax	NULL
transactivation	NULL
of	NULL
the	NULL
E2F-1	NULL
promoter	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
ATF	NULL
pathway	NULL
.	NULL

A	NULL
,	NULL
CEM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pGL2-AN	NULL
containing	NULL
E2F-1	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
together	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pSG-5	NULL
,	NULL
pSG-Tax	NULL
,	NULL
pSG-Tax	NULL
M22	NULL
,	NULL
or	NULL
pSG-Tax	NULL
M47	NULL
.	NULL

Luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

pGL2-AN	NULL
in	NULL
absence	NULL
of	NULL
Tax	NULL
was	NULL
arbitrarily	NULL
given	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
mutated	NULL
Tax	NULL
proteins	NULL
in	NULL
transfected	NULL
cells	NULL
was	NULL
checked	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
luciferase	NULL
activity	NULL
by	NULL
14-fold	NULL
.	NULL

Since	NULL
Tax	NULL
M47	NULL
fails	NULL
to	NULL
activate	NULL
ATF-dependent	NULL
promoters	NULL
,	NULL
this	NULL
stimulation	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
E2F-1	NULL
gene	NULL
through	NULL
the	NULL
ATF	NULL
pathway	NULL
.	NULL

This	NULL
result	NULL
confirms	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
ATF	NULL
pathway	NULL
but	NULL
also	NULL
indicates	NULL
that	NULL
other	NULL
activation	NULL
mechanisms	NULL
could	NULL
contribute	NULL
to	NULL
E2F-1	NULL
stimulation	NULL
by	NULL
Tax	NULL
.	NULL

DISCUSSION	NULL
The	NULL
regulation	NULL
of	NULL
E2F	NULL
is	NULL
a	NULL
key	NULL
target	NULL
for	NULL
oncoviruses	NULL
.	NULL

Binding	NULL
of	NULL
pRB	NULL
and	NULL
the	NULL
other	NULL
pocket	NULL
proteins	NULL
to	NULL
ligands	NULL
such	NULL
as	NULL
,	NULL
adenovirus	NULL
ELA	NULL
,	NULL
simian	NULL
virus	NULL
large	NULL
T	NULL
antigen	NULL
,	NULL
and	NULL
papilloma-virus	NULL
E7	NULL
,	NULL
leads	NULL
to	NULL
a	NULL
stimulation	NULL
of	NULL
E2F	NULL
-dependent	NULL
transcription	NULL
and	NULL
cellular	NULL
transformation	NULL
(	NULL
54-56	NULL
)	NULL
.	NULL

The	NULL
human	NULL
cytomegalov-irus	NULL
IE72	NULL
protein	NULL
is	NULL
able	NULL
to	NULL
phosphorylate	NULL
E2F-1-3	NULL
and	NULL
the	NULL
pocket	NULL
proteins	NULL
p107	NULL
and	NULL
p130	NULL
,	NULL
and	NULL
this	NULL
phosphorylation	NULL
step	NULL
would	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
E2F	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
HTLV-I-infected	NULL
T-cell	NULL
lines	NULL
and	NULL
leukemic	NULL
cells	NULL
obtained	NULL
from	NULL
ATL	NULL
patients	NULL
(	NULL
31	NULL
)	NULL
suggests	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
E2F-dependent	NULL
transcription	NULL
by	NULL
HTLV-I	NULL
could	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
prolifer-ative	NULL
response	NULL
during	NULL
HTLV-I	NULL
infection	NULL
.	NULL

Suzuki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
demonstrated	NULL
that	NULL
Tax	NULL
interacted	NULL
with	NULL
p16	NULL
``	NULL
~**	NULL
``	NULL
and	NULL
suggested	NULL
that	NULL
the	NULL
inactivation	NULL
of	NULL
p16	NULL
``	NULL
~**	NULL
``	NULL
by	NULL
Tax	NULL
would	NULL
contribute	NULL
to	NULL
cellular	NULL
immortalization	NULL
and	NULL
transformation	NULL
induced	NULL
by	NULL
HTLV-I	NULL
infection	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
Tax	NULL
released	NULL
T-lymphocytes	NULL
from	NULL
cell	NULL
cycle	NULL
arrest	NULL
induced	NULL
by	NULL
but	NULL
also	NULL
that	NULL
p16	NULL
``	NULL
~**	NULL
``	NULL
overexpression	NULL
blocked	NULL
Tax-dependent	NULL
stimulation	NULL
of	NULL
DNA	NULL
synthesis	NULL
(	NULL
34	NULL
)	NULL
are	NULL
effectively	NULL
consistent	NULL
with	NULL
a	NULL
deregulation	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
by	NULL
Tax	NULL
in	NULL
a	NULL
pendent	NULL
manner	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
did	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Tax	NULL
could	NULL
also	NULL
activate	NULL
E2F-dependent	NULL
transcription	NULL
in	NULL
a	NULL
p16	NULL
``	NULL
~**-independent	NULL
manner	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Tax	NULL
stimulates	NULL
the	NULL
activity	NULL
of	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
in	NULL
CEM	NULL
T-cells	NULL
,	NULL
which	NULL
lack	NULL
expression	NULL
of	NULL
p16	NULL
'	NULL
``	NULL
~*	NULL
``	NULL
.	NULL

This	NULL
stimulation	NULL
is	NULL
abrogated	NULL
by	NULL
mutations	NULL
affecting	NULL
the	NULL
E2F	NULL
binding	NULL
sites	NULL
,	NULL
thereby	NULL
confirming	NULL
that	NULL
stimulation	NULL
by	NULL
Tax	NULL
is	NULL
due	NULL
to	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
to	NULL
E2F	NULL
boxes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
(	NULL
i	NULL
)	NULL
Tax	NULL
stimulates	NULL
E2F-1	NULL
mRNA	NULL
synthesis	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
Tax	NULL
transactivates	NULL
the	NULL
E2F-1	NULL
promoter	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
this	NULL
transactivation	NULL
is	NULL
dependent	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
on	NULL
the	NULL
ATF	NULL
pathway	NULL
.	NULL

Tax	NULL
is	NULL
well	NULL
known	NULL
to	NULL
interact	NULL
directly	NULL
with	NULL
proteins	NULL
of	NULL
the	NULL
ATF/CREB	NULL
family	NULL
and	NULL
to	NULL
stimulate	NULL
their	NULL
activity	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Tax	NULL
interaction	NULL
with	NULL
the	NULL
ATF	NULL
pathway	NULL
is	NULL
important	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
neoplastic	NULL
phenotype	NULL
in	NULL
the	NULL
case	NULL
of	NULL
adult	NULL
rat	NULL
fibroblasts	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
mutants	NULL
of	NULL
Tax	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
endogenous	NULL
Fold	NULL
increase	NULL
vs	NULL
pGL2-basic	NULL
ad	NULL
s	NULL
n	NULL
w	NULL
n	NULL
o	NULL
Pd	NULL
®	NULL
©	NULL
o	NULL
&	NULL
o	NULL
OOT	NULL
w	NULL
o	NULL
sl	NULL
LUCIFERASE	NULL
LUCIFERASE	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

5	NULL
'	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
EZF-1	NULL
promoter	NULL
by	NULL
Tax	NULL
.	NULL

CEM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
E2F-1	NULL
promoter	NULL
fragment	NULL
and	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pSG-5	NULL
(	NULL
white	NULL
)	NULL
or	NULL
pSG-Tax	NULL
(	NULL
black	NULL
)	NULL
.	NULL

48	NULL
h	NULL
later	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
-galactosidase	NULL
activity	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
-fold	NULL
increase	NULL
relative	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
pGL2-basic	NULL
alone	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

The	NULL
E2F-1	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
,	NULL
with	NULL
the	NULL
locations	NULL
of	NULL
two	NULL
CCAAT	NULL
boxes	NULL
and	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
MBF-1	NULL
,	NULL
Sp-1	NULL
,	NULL
ATF	NULL
,	NULL
E4F	NULL
,	NULL
and	NULL
E2F	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
50	NULL
J	NULL
40	NULL
7	NULL
]	NULL
30	NULL
-I	NULL
20	NULL
1047	NULL
Relative	NULL
luciferase	NULL
activity	NULL
E2F-Box	NULL
-	NULL
]	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
M22	NULL
E2E-Box	NULL
+	NULL
E2F-1	NULL
+Tax	NULL
M47	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
Tax	NULL
M47	NULL
on	NULL
the	NULL
transactivation	NULL
of	NULL
EZF-1	NULL
.	NULL

CEM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
pCMV-E2F-1	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
pDP1	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
p8xE2F-WT-luc	NULL
(	NULL
E2F-Box	NULL
)	NULL
together	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
either	NULL
pSG-5	NULL
(	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
)	NULL
,	NULL
or	NULL
pSG-Tax	NULL
(	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax	NULL
)	NULL
,	NULL
or	NULL
pSG-Tax	NULL
M22	NULL
(	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax-M22	NULL
)	NULL
,	NULL
or	NULL
pSG-Tax	NULL
M47	NULL
(	NULL
E2F-Box	NULL
+	NULL
E2F-1	NULL
+	NULL
Tax-M47	NULL
)	NULL
.	NULL

Luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
E2F-Box	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
E2F-1	NULL
was	NULL
arbitrarily	NULL
given	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

ATF	NULL
pathway	NULL
,	NULL
had	NULL
a	NULL
reduced	NULL
ability	NULL
to	NULL
induce	NULL
tumors	NULL
in	NULL
trans-genic	NULL
mice	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
E2F-1	NULL
mRNA	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Overproduction	NULL
of	NULL
E2F-1	NULL
can	NULL
induce	NULL
cell	NULL
proliferation	NULL
,	NULL
presumably	NULL
by	NULL
titrating	NULL
pRB	NULL
from	NULL
the	NULL
relevant	NULL
promoter	NULL
and	NULL
thus	NULL
leading	NULL
resting	NULL
cells	NULL
to	NULL
inappropriate	NULL
entry	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
59	NULL
,	NULL
60	NULL
)	NULL
,	NULL
but	NULL
can	NULL
also	NULL
induce	NULL
p53-dependent	NULL
apoptosis	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
p53	NULL
is	NULL
fully	NULL
inactivated	NULL
by	NULL
Tax	NULL
in	NULL
the	NULL
HTLV-I-transformed	NULL
T-cells	NULL
(	NULL
63	NULL
,	NULL
64	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
stimulation	NULL
of	NULL
E2F-1	NULL
gene	NULL
by	NULL
Tax	NULL
could	NULL
effectively	NULL
be	NULL
involved	NULL
in	NULL
T-cell	NULL
transformation	NULL
.	NULL

The	NULL
activation	NULL
by	NULL
ATF	NULL
pathway	NULL
of	NULL
the	NULL
E2F-1	NULL
promoter	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
completely	NULL
explain	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
E2F-mediated	NULL
transcription	NULL
in	NULL
T-cells	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
mutant	NULL
Tax	NULL
M47	NULL
that	NULL
fails	NULL
to	NULL
activate	NULL
ATF	NULL
pathway	NULL
remains	NULL
able	NULL
to	NULL
transactivate	NULL
exogenous	NULL
E2F-1	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
mech-anism	NULL
,	NULL
not	NULL
yet	NULL
characterized	NULL
,	NULL
could	NULL
be	NULL
also	NULL
involved	NULL
in	NULL
a	NULL
p16	NULL
``	NULL
~	NULL
``	NULL
*	NULL
``	NULL
-independent	NULL
activation	NULL
of	NULL
E2F-mediated	NULL
transcription	NULL
by	NULL
Tax	NULL
.	NULL

Growth	NULL
factors	NULL
such	NULL
as	NULL
IL-2	NULL
are	NULL
necessary	NULL
to	NULL
carry	NULL
T-cells	NULL
from	NULL
the	NULL
G1	NULL
to	NULL
the	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
stimulate	NULL
the	NULL
transcription	NULL
of	NULL
IL-2	NULL
and	NULL
to	NULL
trigger	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
its	NULL
receptor	NULL
,	NULL
IL-2Ra	NULL
,	NULL
has	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
constitutive	NULL
signaling	NULL
by	NULL
the	NULL
IL-2	NULL
receptor	NULL
may	NULL
be	NULL
a	NULL
key	NULL
factor	NULL
in	NULL
developing	NULL
ATL	NULL
(	NULL
65	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
progression	NULL
from	NULL
IL-2	NULL
dependence	NULL
to	NULL
independence	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
HTLV-I	NULL
immortalized	NULL
cells	NULL
(	NULL
66-68	NULL
)	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
was	NULL
recently	NULL
reported	NULL
as	NULL
being	NULL
unnecessary	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
growth	NULL
of	NULL
HTLV-I	NULL
transformed	NULL
cell	NULL
lines	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Signaling	NULL
cascades	NULL
initiated	NULL
by	NULL
IL-2	NULL
include	NULL
protein	NULL
kinase-de-pendent	NULL
pathways	NULL
involving	NULL
the	NULL
Lick	NULL
and	NULL
Fyn	NULL
kinases	NULL
(	NULL
70	NULL
)	NULL
,	NULL
two	NULL
Janus	NULL
family	NULL
kinases	NULL
,	NULL
Jaks	NULL
1	NULL
and	NULL
3	NULL
(	NULL
71	NULL
,	NULL
72	NULL
)	NULL
,	NULL
and	NULL
the	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI3SK	NULL
)	NULL
(	NULL
73	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
neither	NULL
the	NULL
Lick	NULL
nor	NULL
the	NULL
Fyn	NULL
kinases	NULL
are	NULL
expressed	NULL
in	NULL
HTLV-I-infected	NULL
human	NULL
T-cells	NULL
(	NULL
17	NULL
,	NULL
74	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
Jak/STAT	NULL
pathway	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
HTLV-I	NULL
immortalized	NULL
cells	NULL
(	NULL
75	NULL
,	NULL
76	NULL
)	NULL
suggesting	NULL
that	NULL
this	NULL
pathway	NULL
could	NULL
participate	NULL
in	NULL
HTLV-I-mediated	NULL
T-cell	NULL
transformation	NULL
.	NULL

Although	NULL
the	NULL
mecha-	NULL
23603	NULL
nism	NULL
by	NULL
which	NULL
HTLV-I	NULL
transformation	NULL
induces	NULL
activation	NULL
of	NULL
the	NULL
Jak	NULL
pathway	NULL
is	NULL
not	NULL
well	NULL
understood	NULL
,	NULL
Tax	NULL
is	NULL
probably	NULL
not	NULL
involved	NULL
in	NULL
this	NULL
activation	NULL
(	NULL
75	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
PI3SK	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
couple	NULL
the	NULL
IL-2R	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
E2F	NULL
in	NULL
T-cells	NULL
(	NULL
73	NULL
)	NULL
,	NULL
E2F	NULL
transcriptional	NULL
activity	NULL
being	NULL
regulated	NULL
by	NULL
the	NULL
action	NULL
of	NULL
PI3K	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
B.	NULL
Inhibition	NULL
of	NULL
PI3K	NULL
inhibits	NULL
phosphorylation	NULL
of	NULL
pRB	NULL
,	NULL
induction	NULL
of	NULL
cyclin	NULL
D3	NULL
,	NULL
and	NULL
degradation	NULL
of	NULL
p27**	NULL
``	NULL
'	NULL
(	NULL
73	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
establish	NULL
a	NULL
crucial	NULL
PI3K/protein	NULL
kinase	NULL
B-mediated	NULL
link	NULL
between	NULL
the	NULL
IL-2	NULL
receptor	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
machinery	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
direct	NULL
activation	NULL
of	NULL
this	NULL
pathway	NULL
by	NULL
Tax	NULL
could	NULL
contribute	NULL
to	NULL
explain	NULL
the	NULL
activation	NULL
of	NULL
E2F-mediated	NULL
transcription	NULL
by	NULL
Tax	NULL
and	NULL
the	NULL
switch	NULL
to	NULL
IL-2	NULL
independence	NULL
in	NULL
HTLV-I	NULL
immortalized	NULL
cells	NULL
.	NULL

Yet	NULL
other	NULL
mechanisms	NULL
could	NULL
explain	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
including	NULL
,	NULL
for	NULL
example	NULL
,	NULL
the	NULL
direct	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
E2F-1	NULL
,	NULL
as	NULL
described	NULL
for	NULL
several	NULL
cellular	NULL
transcriptional	NULL
factors	NULL
.	NULL

Experiments	NULL
are	NULL
under	NULL
way	NULL
to	NULL
further	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
Tax	NULL
in	NULL
E2F-mediated	NULL
transcription	NULL
independently	NULL
on	NULL
p16	NULL
``	NULL
~***	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
this	NULL
novel	NULL
mechanism	NULL
will	NULL
provide	NULL
a	NULL
useful	NULL
tool	NULL
to	NULL
understand	NULL
how	NULL
HTLV-I	NULL
could	NULL
induce	NULL
T-cell	NULL
transformation	NULL
.	NULL

Addendum-During	NULL
the	NULL
submission	NULL
of	NULL
this	NULL
paper	NULL
,	NULL
Neuveut	NULL
et	NULL
al	NULL
.	NULL

(	NULL
77	NULL
)	NULL
published	NULL
results	NULL
indicating	NULL
that	NULL
Tax	NULL
can	NULL
increase	NULL
cyclin	NULL
D-edk	NULL
activity	NULL
and	NULL
induce	NULL
a	NULL
phosphorylation	NULL
of	NULL
cyclin	NULL
D8	NULL
in	NULL
T-cells	NULL
null	NULL
for	NULL
p16	NULL
``	NULL
~*	NULL
``	NULL
4	NULL
.	NULL

They	NULL
suggested	NULL
that	NULL
this	NULL
Tax-associated	NULL
phosphorylation	NULL
of	NULL
cyclin	NULL
D3	NULL
might	NULL
stabilize	NULL
the	NULL
cyclin-cdk	NULL
complexes	NULL
,	NULL
and	NULL
thus	NULL
enhance	NULL
the	NULL
pRB	NULL
phosphorylation	NULL
and	NULL
increase	NULL
the	NULL
E2F	NULL
transcriptional	NULL
activity	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
W.	NULL
G.	NULL
Kaelin	NULL
for	NULL
the	NULL
deleted	NULL
E2F-1	NULL
promoter	NULL
constructions	NULL
;	NULL
P.	NULL
Jalinot	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
the	NULL
Tax	NULL
expression	NULL
vector	NULL
and	NULL
the	NULL
Tax	NULL
mutants	NULL
M9	NULL
,	NULL
M21	NULL
,	NULL
M22	NULL
,	NULL
and	NULL
M47	NULL
;	NULL
and	NULL
L.	NULL
Gazzolo	NULL
and	NULL
K.	NULL
Sugamure	NULL
for	NULL
the	NULL
Jurkat	NULL
cell	NULL
lines	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Sato	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
713-718	NULL
2	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
,	NULL
Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
and	NULL
Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
6558-6562	NULL
3	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Teruuchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miwa	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8112-8116	NULL
4	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Boros	NULL
,	NULL
L.	NULL
,	NULL
Brady	NULL
,	NULL
J.	NULL
,	NULL
Radonovich	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Khoury	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
4499-4509	NULL
5	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7070-7074	NULL
6	NULL
.	NULL

Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Kubik	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Uittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
Utaisincharcen	NULL
,	NULL
P.	NULL
,	NULL
Matthews	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21225-21231	NULL
7	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Toita	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
610-614	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
895-399	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Laurance	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Lundblad	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Goldman	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Shih	NULL
,	NULL
H.	NULL
,	NULL
Connor	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Marriott	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
880	NULL
,	NULL
642-646	NULL
10	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
Tsuchiya	NULL
,	NULL
H.	NULL
,	NULL
Chubjo	NULL
,	NULL
T.	NULL
,	NULL
Akizawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Seiki	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
2066-2076	NULL
11	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
Petropoulos	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Lacoste	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Virology	NULL
214	NULL
,	NULL
3-11	NULL
12	NULL
.	NULL

Dittmer	NULL
,	NULL
J.	NULL
,	NULL
Pise-Masison	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Clemens	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Choi	NULL
,	NULL
K.-S.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
4953-4958	NULL
13	NULL
.	NULL

Pise-Masison	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Dittmer	NULL
,	NULL
J.	NULL
,	NULL
Clemens	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
1236-1248	NULL
14	NULL
.	NULL

Trejot	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Ratner	NULL
,	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
27411-27421	NULL
15	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Widen	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Semmes	NULL
IV	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1082-1084	NULL
16	NULL
.	NULL

Uittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Armstrong	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Chiaramello	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
22466-22469	NULL
17	NULL
.	NULL

Lemasson	NULL
,	NULL
I.	NULL
,	NULL
Robert-Hebmann	NULL
,	NULL
V.	NULL
,	NULL
Hamaia	NULL
,	NULL
S.	NULL
,	NULL
Duc	NULL
Dodon	NULL
,	NULL
M.	NULL
,	NULL
Gazzolo	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Devaux	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
1975-1983	NULL
18	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1875-1885	NULL
19	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
1038-1042	NULL
20	NULL
.	NULL

Yamaoka	NULL
,	NULL
S.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
Sakurai	NULL
,	NULL
M.	NULL
,	NULL
Sugiyama	NULL
,	NULL
T.	NULL
,	NULL
Hazama	NULL
,	NULL
M.	NULL
,	NULL
Yamada	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Hatanaka	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
873-887	NULL
21	NULL
.	NULL

Rosin	NULL
,	NULL
O.	NULL
,	NULL
Koch	NULL
,	NULL
C.	NULL
,	NULL
Schmitt	NULL
,	NULL
I.	NULL
,	NULL
Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
and	NULL
Grassmann	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
6698-6703	NULL
22	NULL
.	NULL

Huber	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Edwards	NULL
,	NULL
G.	NULL
,	NULL
Goodhart	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Patrick	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Huang	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ivey-Hoyle	NULL
,	NULL
M.	NULL
,	NULL
Barnett	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Oliff	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Heimbrook	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3525-3529	NULL
23	NULL
.	NULL

La	NULL
Thangue	NULL
,	NULL
N.	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
108-114	NULL
24	NULL
.	NULL

Adams	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
99-108	NULL
25	NULL
.	NULL

Krek	NULL
,	NULL
W.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Shirodkar	NULL
,	NULL
S.	NULL
,	NULL
Arany	NULL
,	NULL
Z.	NULL
,	NULL
Kaelin	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
161-172	NULL
w	NULL
co	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
28604	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Girling	NULL
,	NULL
R.	NULL
,	NULL
Partridge	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Bandara	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Burden	NULL
,	NULL
N.	NULL
,	NULL
Totty	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Hsuan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
La	NULL
,	NULL
T.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
362	NULL
,	NULL
88-87	NULL
Ormondroyd	NULL
,	NULL
E.	NULL
,	NULL
De	NULL
La	NULL
Luna	NULL
,	NULL
S	NULL
,	NULL
and	NULL
La	NULL
,	NULL
T.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1487-1446	NULL
Zhang	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Chellappan	NULL
,	NULL
S.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
2085-2093	NULL
Wade	NULL
,	NULL
M.	NULL
,	NULL
Blake	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Jambou	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Helin	NULL
,	NULL
K.	NULL
,	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Azizkhan	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9783-9791	NULL
Moberg	NULL
,	NULL
K.	NULL
,	NULL
Starz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1436-1449	NULL
Mori	NULL
,	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

58	NULL
,	NULL
114-120	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

AIDS	NULL
Hum	NULL
.	NULL

Retrovirol	NULL
.	NULL

18	NULL
,	NULL
S63-568	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Kitao	NULL
,	NULL
S.	NULL
,	NULL
Matsushime	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1607-1614	NULL
Low	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Dorner	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Fernando	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Grossman	NULL
,	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
and	NULL
Comb	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
1956-1962	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
424-429	NULL
Johnson	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Cress	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Jakoi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
12828-12827	NULL
Xu	NULL
,	NULL
G.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Krek	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
1357-1361	NULL
Yang	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
and	NULL
Sladek	NULL
,	NULL
T.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Gene	NULL
Expr	NULL
.	NULL

4	NULL
,	NULL
195-204	NULL
Miyoshi	NULL
,	NULL
L.	NULL
,	NULL
Taguchi	NULL
,	NULL
H.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
,	NULL
Shiraishi	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Akagi	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
Gann	NULL
28	NULL
,	NULL
219-228	NULL
Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
Markham	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Franchini	NULL
,	NULL
G.	NULL
,	NULL
Kalyaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Virology	NULL
129	NULL
,	NULL
51-64	NULL
Corbeil	NULL
,	NULL
J.	NULL
,	NULL
Tremblay	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Richman	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
,	NULL
89-48	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Ohtani	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
3220-3226	NULL
Rousset	NULL
,	NULL
R.	NULL
,	NULL
Desbois	NULL
,	NULL
C.	NULL
,	NULL
Bantignies	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Jalinot	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
381	NULL
,	NULL
328-331	NULL
Krek	NULL
,	NULL
W.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Shirodkar	NULL
,	NULL
S.	NULL
(	NULL
19983	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1557-1560	NULL
Geng	NULL
,	NULL
Y.	NULL
,	NULL
Eaton	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
Picon	NULL
,	NULL
M.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lundberg	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
,	NULL
Sardet	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Oncogene	NULL
12	NULL
,	NULL
1173-1180	NULL
Helin	NULL
,	NULL
K.	NULL
,	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Fattaey	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6501-6508	NULL
Sardet	NULL
,	NULL
C.	NULL
,	NULL
Vidal	NULL
,	NULL
M.	NULL
,	NULL
Cobrinik	NULL
,	NULL
D.	NULL
,	NULL
Geng	NULL
,	NULL
Y.	NULL
,	NULL
Onufryk	NULL
,	NULL
C.	NULL
,	NULL
Chen	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
2408-2407	NULL
Neuman	NULL
,	NULL
E.	NULL
,	NULL
Flemington	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Sellers	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
and	NULL
Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6607-6615	NULL
Lemasson	NULL
,	NULL
I.	NULL
,	NULL
Briant	NULL
,	NULL
L.	NULL
,	NULL
Hague	NULL
,	NULL
B.	NULL
,	NULL
Coudronni¢re	NULL
,	NULL
N.	NULL
,	NULL
Heron	NULL
,	NULL
L.	NULL
,	NULL
David	NULL
,	NULL
C.	NULL
,	NULL
Rebouissou	NULL
,	NULL
C.	NULL
,	NULL
Kindt	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Devaux	NULL
,	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
859-865	NULL
Langton	NULL
,	NULL
B.	NULL
C.	NULL
,	NULL
Sliwkoski	NULL
,	NULL
M.	NULL
,	NULL
Tran	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
Knapp	NULL
,	NULL
S.	NULL
,	NULL
Keitelman	NULL
,	NULL
E.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Wallingford	NULL
,	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
H.-L.	NULL
,	NULL
Ralston	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Brandis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Coates	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Med	NULL
.	NULL

Virol	NULL
.	NULL

8	NULL
,	NULL
295-301	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
5581-5587	NULL
Paul	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Novak	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Sarr	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Ruddle	NULL
,	NULL
N.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
5412-5419	NULL
Duyao	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Spicer	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Bartholomew	NULL
,	NULL
C.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
16288-16291	NULL
Dyson	NULL
,	NULL
N.	NULL
,	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Munger	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

TL	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

Tax	NULL
Transactivation	NULL
of	NULL
E2F-dependent	NULL
Transcription	NULL
934-937	NULL
Whyte	NULL
,	NULL
P.	NULL
,	NULL
Williamson	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
67-75	NULL
Chellappan	NULL
,	NULL
S.	NULL
,	NULL
Kraus	NULL
,	NULL
V.	NULL
B.	NULL
,	NULL
Kroger	NULL
,	NULL
B.	NULL
,	NULL
Munger	NULL
,	NULL
K.	NULL
,	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Phelps	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

No	NULL
#	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
4549-4553	NULL
Pajovie	NULL
,	NULL
S.	NULL
,	NULL
Wong	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Black	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Azizkhan	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
6459-6464	NULL
Franchini	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
3619-3639	NULL
Johnson	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Schwartz	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Cress	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
349-352	NULL
Lukas	NULL
,	NULL
J.	NULL
,	NULL
Petersen	NULL
,	NULL
B.	NULL
O.	NULL
,	NULL
Holm	NULL
,	NULL
K.	NULL
,	NULL
Bartek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Helin	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1047-1057	NULL
Wu	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Levine	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
83602-8606	NULL
Qin	NULL
,	NULL
X.	NULL
Q.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
and	NULL
Adams	NULL
,	NULL
P.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
10918-10922	NULL
TUittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Giebler	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Reisman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
28508-28506	NULL
Pise-Masison	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Choi	NULL
,	NULL
K.-S.	NULL
,	NULL
Radonovich	NULL
,	NULL
M.	NULL
,	NULL
Dittmer	NULL
,	NULL
J.	NULL
,	NULL
Kim	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

72	NULL
,	NULL
1165-1170	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
F.	NULL
,	NULL
Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
348-350	NULL
Popovic	NULL
,	NULL
M.	NULL
,	NULL
Lange-Wantzin	NULL
,	NULL
G.	NULL
,	NULL
Sarin	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Mann	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

80	NULL
,	NULL
5402-5406	NULL
Hoshino	NULL
,	NULL
H.	NULL
,	NULL
Esumi	NULL
,	NULL
H.	NULL
,	NULL
Miwa	NULL
,	NULL
M.	NULL
,	NULL
Shimoyama	NULL
,	NULL
M.	NULL
,	NULL
Minato	NULL
,	NULL
K.	NULL
,	NULL
Tobinai	NULL
,	NULL
K.	NULL
,	NULL
Hirose	NULL
,	NULL
M.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Inada	NULL
,	NULL
N.	NULL
,	NULL
Kinoshita	NULL
,	NULL
K.	NULL
,	NULL
Kamihira	NULL
,	NULL
S.	NULL
,	NULL
Ichimaru	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugimura	NULL
,	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

80	NULL
,	NULL
6061-6065	NULL
Hillsberg	NULL
,	NULL
P.	NULL
,	NULL
Wucherpfennig	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Ausubel	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Calvo	NULL
,	NULL
V.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Hafler	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
8256-3263	NULL
Richardson	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Marasco	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Virology	NULL
287	NULL
,	NULL
209-216	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
251-255	NULL
Johnson	NULL
,	NULL
J.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
O	NULL
.	NULL

1	NULL
(	NULL
994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
151-153	NULL
Russell	NULL
,	NULL
S.	NULL
,	NULL
Johnston	NULL
,	NULL
J.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
,	NULL
Friedman	NULL
,	NULL
M.	NULL
,	NULL
Berg	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
,	NULL
Witthubn	NULL
,	NULL
B.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Schmalstieg	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1042-1045	NULL
Brennan	NULL
,	NULL
P.	NULL
,	NULL
Babbage	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Burgering	NULL
,	NULL
B.	NULL
M.	NULL
T.	NULL
,	NULL
Groner	NULL
,	NULL
B.	NULL
,	NULL
Reif	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Immunity	NULL
7	NULL
,	NULL
679-689	NULL
Mills	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
Arima	NULL
,	NULL
N.	NULL
,	NULL
May	NULL
,	NULL
C.	NULL
,	NULL
Hill	NULL
,	NULL
M.	NULL
,	NULL
Schmandt	NULL
,	NULL
R.	NULL
,	NULL
Li	NULL
,	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

4	NULL
,	NULL
12833-1243	NULL
Migone	NULL
,	NULL
T.-S.	NULL
,	NULL
Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
Cereseto	NULL
,	NULL
A.	NULL
,	NULL
Mulloy	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Franchini	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
79-81	NULL
Takemoto	NULL
,	NULL
S.	NULL
,	NULL
Mulloy	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Cereseto	NULL
,	NULL
A.	NULL
,	NULL
Migone	NULL
,	NULL
T.-S.	NULL
,	NULL
Patel	NULL
,	NULL
B.	NULL
K.	NULL
R.	NULL
,	NULL
Matsuoka	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
K.	NULL
,	NULL
Takatsuki	NULL
,	NULL
K.	NULL
,	NULL
Kamihira	NULL
,	NULL
S.	NULL
,	NULL
White	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Franchini	NULL
,	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
13897-13902	NULL
Neuveut	NULL
,	NULL
C.	NULL
,	NULL
Low	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Maldarelli	NULL
,	NULL
F.	NULL
,	NULL
Schmitt	NULL
,	NULL
I.	NULL
,	NULL
Majone	NULL
,	NULL
F.	NULL
,	NULL
Grassmann	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3620-3632	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Activation	NULL
of	NULL
E2F-mediated	NULL
Transcripiwijf	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
Tax	NULL
Protein	NULL
in	NULL
a	NULL
p16	NULL
-negative	NULL
T-cell	NULL
Line	NULL
Isabelle	NULL
Lemasson	NULL
,	NULL
Sabine	NULL
Thébault	NULL
,	NULL
Claude	NULL
Sardet	NULL
,	NULL
Christian	NULL
Devaux	NULL
and	NULL
Jean-Michel	NULL
Mesnard	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:23598-23604.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.36.23598	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/36/23598	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
77	NULL
references	NULL
,	NULL
50	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

